According to Latest Study , the global market for Neurology Clinical Trial should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Neurology Clinical Trial market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Neurology Clinical Trial market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Bone Marrow segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Neurodegenerative Disorders has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Neurology Clinical Trial include BrainStorm Cell Therapeutics, Opexa Therapeutics, Caladrius Biosciences, U.S. Stem Cell, Lonza, Bristol Myers Squibb, Corning Incorporated, Vericel Corporation and Catalent, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Neurology Clinical Trial. Report Highlights:

(1) Global Neurology Clinical Trial market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Neurology Clinical Trial market competitive situation, revenue and market share, from 2019 to 2024.

(3) China Neurology Clinical Trial market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global Neurology Clinical Trial segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Neurology Clinical Trial segment by type and by application and regional segment by type and by application.

(6) Neurology Clinical Trial industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Bone Marrow

Epidermis

Mesenchymal Stem Cells

Haematopoietic Stem Cells

Chondrocytes

Market segment by application, can be divided into

Neurodegenerative Disorders

Cardiovascular Disorders

Orthopedics

Wound Healing

Other

Market segment by players, this report covers

BrainStorm Cell Therapeutics

Opexa Therapeutics

Caladrius Biosciences

U.S. Stem Cell

Lonza

Bristol Myers Squibb

Corning Incorporated

Vericel Corporation

Catalent

Lineage Cell Therapeutics

Castle Creek Biosciences

Sangamo Therapeutics

Novartis

Holostem Terapie Avanzate S.R.L

Pharmicell

Tego Science

Autolus therapeutics

Bayer AG

Sartorius AG

Daiichi Sankyo

Takeda Pharmaceutical Company

Sumitomo Chemical Co

1 Market Overview

1.1 Product Overview and Scope of Neurology Clinical Trial

1.2 Global Neurology Clinical Trial Market Size and Forecast

1.3 China Neurology Clinical Trial Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Neurology Clinical Trial Share in Global Market, 2019-2030

1.4.2 Neurology Clinical Trial Market Size: China VS Global, 2019-2030

1.5 Neurology Clinical Trial Market Dynamics

1.5.1 Neurology Clinical Trial Market Drivers

1.5.2 Neurology Clinical Trial Market Restraints

1.5.3 Neurology Clinical Trial Industry Trends

1.5.4 Neurology Clinical Trial Industry Policy

2 Global Competitive Situation by Company

2.1 Global Neurology Clinical Trial Revenue by Company (2019-2024)

2.2 Global Neurology Clinical Trial Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Neurology Clinical Trial Concentration Ratio

2.4 Global Neurology Clinical Trial Mergers & Acquisitions, Expansion Plans

2.5 Global Neurology Clinical Trial Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Neurology Clinical Trial Revenue by Company (2019-2024)

3.2 China Neurology Clinical Trial Neurology Clinical Trial Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Neurology Clinical Trial, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Neurology Clinical Trial Industry Chain

4.2 Neurology Clinical Trial Upstream Analysis

4.3 Neurology Clinical Trial Midstream Analysis

4.4 Neurology Clinical Trial Downstream Analysis

5 Sights by Type

5.1 Neurology Clinical Trial Classification

5.1.1 Bone Marrow

5.1.2 Epidermis

5.1.3 Mesenchymal Stem Cells

5.1.4 Haematopoietic Stem Cells

5.1.5 Chondrocytes

5.2 By Type, Global Neurology Clinical Trial Market Size & CAGR, 2019 VS 2023 VS 2030

5.3 By Type, Global Neurology Clinical Trial Revenue, 2019-2030

6 Sights by Application

6.1 Neurology Clinical Trial Segment by Application

6.1.1 Neurodegenerative Disorders

6.1.2 Cardiovascular Disorders

6.1.3 Orthopedics

6.1.4 Wound Healing

6.1.5 Other

6.2 By Application, Global Neurology Clinical Trial Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Application, Global Neurology Clinical Trial Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Neurology Clinical Trial Market Size, 2019 VS 2023 VS 2030

7.2 By Region, Global Neurology Clinical Trial Market Size, 2019-2030

7.3 North America

7.3.1 North America Neurology Clinical Trial Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Neurology Clinical Trial Market Size Market Share

7.4 Europe

7.4.1 Europe Neurology Clinical Trial Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Neurology Clinical Trial Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Neurology Clinical Trial Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Neurology Clinical Trial Market Size Market Share

7.6 South America

7.6.1 South America Neurology Clinical Trial Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Neurology Clinical Trial Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Neurology Clinical Trial Market Size & CAGR，2019 VS 2023 VS 2030

8.2 By Country, Global Neurology Clinical Trial Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Neurology Clinical Trial Market Size, 2019-2030

8.3.2 By Company, U.S. Neurology Clinical Trial Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Neurology Clinical Trial Market Size, 2019-2030

8.4.2 By Company, Europe Neurology Clinical Trial Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Neurology Clinical Trial Market Size, 2019-2030

8.5.2 By Company, China Neurology Clinical Trial Revenue Market Share, 2019-2024

8.5.3 By Type, China Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Neurology Clinical Trial Market Size, 2019-2030

8.6.2 By Company, Japan Neurology Clinical Trial Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Neurology Clinical Trial Market Size, 2019-2030

8.7.2 By Company, South Korea Neurology Clinical Trial Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Neurology Clinical Trial Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Neurology Clinical Trial Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Neurology Clinical Trial Market Size, 2019-2030

8.9.2 By Company, India Neurology Clinical Trial Revenue Market Share, 2019-2024

8.9.3 By Type, India Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Neurology Clinical Trial Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Neurology Clinical Trial Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Neurology Clinical Trial Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 BrainStorm Cell Therapeutics

9.1.1 BrainStorm Cell Therapeutics Company Information, Head Office, Market Area and Industry Position

9.1.2 BrainStorm Cell Therapeutics Company Profile and Main Business

9.1.3 BrainStorm Cell Therapeutics Neurology Clinical Trial Models, Specifications and Application

9.1.4 BrainStorm Cell Therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.1.5 BrainStorm Cell Therapeutics Recent Developments

9.2 Opexa Therapeutics

9.2.1 Opexa Therapeutics Company Information, Head Office, Market Area and Industry Position

9.2.2 Opexa Therapeutics Company Profile and Main Business

9.2.3 Opexa Therapeutics Neurology Clinical Trial Models, Specifications and Application

9.2.4 Opexa Therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.2.5 Opexa Therapeutics Recent Developments

9.3 Caladrius Biosciences

9.3.1 Caladrius Biosciences Company Information, Head Office, Market Area and Industry Position

9.3.2 Caladrius Biosciences Company Profile and Main Business

9.3.3 Caladrius Biosciences Neurology Clinical Trial Models, Specifications and Application

9.3.4 Caladrius Biosciences Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.3.5 Caladrius Biosciences Recent Developments

9.4 U.S. Stem Cell

9.4.1 U.S. Stem Cell Company Information, Head Office, Market Area and Industry Position

9.4.2 U.S. Stem Cell Company Profile and Main Business

9.4.3 U.S. Stem Cell Neurology Clinical Trial Models, Specifications and Application

9.4.4 U.S. Stem Cell Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.4.5 U.S. Stem Cell Recent Developments

9.5 Lonza

9.5.1 Lonza Company Information, Head Office, Market Area and Industry Position

9.5.2 Lonza Company Profile and Main Business

9.5.3 Lonza Neurology Clinical Trial Models, Specifications and Application

9.5.4 Lonza Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.5.5 Lonza Recent Developments

9.6 Bristol Myers Squibb

9.6.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position

9.6.2 Bristol Myers Squibb Company Profile and Main Business

9.6.3 Bristol Myers Squibb Neurology Clinical Trial Models, Specifications and Application

9.6.4 Bristol Myers Squibb Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.6.5 Bristol Myers Squibb Recent Developments

9.7 Corning Incorporated

9.7.1 Corning Incorporated Company Information, Head Office, Market Area and Industry Position

9.7.2 Corning Incorporated Company Profile and Main Business

9.7.3 Corning Incorporated Neurology Clinical Trial Models, Specifications and Application

9.7.4 Corning Incorporated Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.7.5 Corning Incorporated Recent Developments

9.8 Vericel Corporation

9.8.1 Vericel Corporation Company Information, Head Office, Market Area and Industry Position

9.8.2 Vericel Corporation Company Profile and Main Business

9.8.3 Vericel Corporation Neurology Clinical Trial Models, Specifications and Application

9.8.4 Vericel Corporation Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.8.5 Vericel Corporation Recent Developments

9.9 Catalent

9.9.1 Catalent Company Information, Head Office, Market Area and Industry Position

9.9.2 Catalent Company Profile and Main Business

9.9.3 Catalent Neurology Clinical Trial Models, Specifications and Application

9.9.4 Catalent Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.9.5 Catalent Recent Developments

9.10 Lineage Cell Therapeutics

9.10.1 Lineage Cell Therapeutics Company Information, Head Office, Market Area and Industry Position

9.10.2 Lineage Cell Therapeutics Company Profile and Main Business

9.10.3 Lineage Cell Therapeutics Neurology Clinical Trial Models, Specifications and Application

9.10.4 Lineage Cell Therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.10.5 Lineage Cell Therapeutics Recent Developments

9.11 Castle Creek Biosciences

9.11.1 Castle Creek Biosciences Company Information, Head Office, Market Area and Industry Position

9.11.2 Castle Creek Biosciences Company Profile and Main Business

9.11.3 Castle Creek Biosciences Neurology Clinical Trial Models, Specifications and Application

9.11.4 Castle Creek Biosciences Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.11.5 Castle Creek Biosciences Recent Developments

9.12 Sangamo Therapeutics

9.12.1 Sangamo Therapeutics Company Information, Head Office, Market Area and Industry Position

9.12.2 Sangamo Therapeutics Company Profile and Main Business

9.12.3 Sangamo Therapeutics Neurology Clinical Trial Models, Specifications and Application

9.12.4 Sangamo Therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.12.5 Sangamo Therapeutics Recent Developments

9.13 Novartis

9.13.1 Novartis Company Information, Head Office, Market Area and Industry Position

9.13.2 Novartis Company Profile and Main Business

9.13.3 Novartis Neurology Clinical Trial Models, Specifications and Application

9.13.4 Novartis Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.13.5 Novartis Recent Developments

9.14 Holostem Terapie Avanzate S.R.L

9.14.1 Holostem Terapie Avanzate S.R.L Company Information, Head Office, Market Area and Industry Position

9.14.2 Holostem Terapie Avanzate S.R.L Company Profile and Main Business

9.14.3 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Models, Specifications and Application

9.14.4 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.14.5 Holostem Terapie Avanzate S.R.L Recent Developments

9.15 Pharmicell

9.15.1 Pharmicell Company Information, Head Office, Market Area and Industry Position

9.15.2 Pharmicell Company Profile and Main Business

9.15.3 Pharmicell Neurology Clinical Trial Models, Specifications and Application

9.15.4 Pharmicell Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.15.5 Pharmicell Recent Developments

9.16 Tego Science

9.16.1 Tego Science Company Information, Head Office, Market Area and Industry Position

9.16.2 Tego Science Company Profile and Main Business

9.16.3 Tego Science Neurology Clinical Trial Models, Specifications and Application

9.16.4 Tego Science Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.16.5 Tego Science Recent Developments

9.17 Autolus therapeutics

9.17.1 Autolus therapeutics Company Information, Head Office, Market Area and Industry Position

9.17.2 Autolus therapeutics Company Profile and Main Business

9.17.3 Autolus therapeutics Neurology Clinical Trial Models, Specifications and Application

9.17.4 Autolus therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.17.5 Autolus therapeutics Recent Developments

9.18 Bayer AG

9.18.1 Bayer AG Company Information, Head Office, Market Area and Industry Position

9.18.2 Bayer AG Company Profile and Main Business

9.18.3 Bayer AG Neurology Clinical Trial Models, Specifications and Application

9.18.4 Bayer AG Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.18.5 Bayer AG Recent Developments

9.19 Sartorius AG

9.19.1 Sartorius AG Company Information, Head Office, Market Area and Industry Position

9.19.2 Sartorius AG Company Profile and Main Business

9.19.3 Sartorius AG Neurology Clinical Trial Models, Specifications and Application

9.19.4 Sartorius AG Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.19.5 Sartorius AG Recent Developments

9.20 Daiichi Sankyo

9.20.1 Daiichi Sankyo Company Information, Head Office, Market Area and Industry Position

9.20.2 Daiichi Sankyo Company Profile and Main Business

9.20.3 Daiichi Sankyo Neurology Clinical Trial Models, Specifications and Application

9.20.4 Daiichi Sankyo Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.20.5 Daiichi Sankyo Recent Developments

9.21 Takeda Pharmaceutical Company

9.21.1 Takeda Pharmaceutical Company Company Information, Head Office, Market Area and Industry Position

9.21.2 Takeda Pharmaceutical Company Company Profile and Main Business

9.21.3 Takeda Pharmaceutical Company Neurology Clinical Trial Models, Specifications and Application

9.21.4 Takeda Pharmaceutical Company Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.21.5 Takeda Pharmaceutical Company Recent Developments

9.22 Sumitomo Chemical Co

9.22.1 Sumitomo Chemical Co Company Information, Head Office, Market Area and Industry Position

9.22.2 Sumitomo Chemical Co Company Profile and Main Business

9.22.3 Sumitomo Chemical Co Neurology Clinical Trial Models, Specifications and Application

9.22.4 Sumitomo Chemical Co Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

9.22.5 Sumitomo Chemical Co Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Neurology Clinical Trial Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Neurology Clinical Trial Market Restraints

Table 3. Neurology Clinical Trial Market Trends

Table 4. Neurology Clinical Trial Industry Policy

Table 5. Global Neurology Clinical Trial Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Neurology Clinical Trial Revenue Market Share by Company (2019-2024)

Table 7. Global Neurology Clinical Trial Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Neurology Clinical Trial Mergers & Acquisitions, Expansion Plans

Table 9. Global Neurology Clinical Trial Manufacturers Product Type

Table 10. China Neurology Clinical Trial Revenue by Company (2019-2024) & (US$ million)

Table 11. China Neurology Clinical Trial Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Neurology Clinical Trial Upstream (Raw Materials)

Table 13. Global Neurology Clinical Trial Typical Customers

Table 14. Neurology Clinical Trial Typical Distributors

Table 15. By Type, Global Neurology Clinical Trial Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Neurology Clinical Trial Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Neurology Clinical Trial Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Neurology Clinical Trial Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Neurology Clinical Trial Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Neurology Clinical Trial Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Neurology Clinical Trial Revenue Market Share, 2019-2030

Table 22. BrainStorm Cell Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 23. BrainStorm Cell Therapeutics Company Profile and Main Business

Table 24. BrainStorm Cell Therapeutics Neurology Clinical Trial Models, Specifications and Application

Table 25. BrainStorm Cell Therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 26. BrainStorm Cell Therapeutics Recent Developments

Table 27. Opexa Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 28. Opexa Therapeutics Company Profile and Main Business

Table 29. Opexa Therapeutics Neurology Clinical Trial Models, Specifications and Application

Table 30. Opexa Therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 31. Opexa Therapeutics Recent Developments

Table 32. Caladrius Biosciences Company Information, Head Office, Market Area and Industry Position

Table 33. Caladrius Biosciences Company Profile and Main Business

Table 34. Caladrius Biosciences Neurology Clinical Trial Models, Specifications and Application

Table 35. Caladrius Biosciences Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 36. Caladrius Biosciences Recent Developments

Table 37. U.S. Stem Cell Company Information, Head Office, Market Area and Industry Position

Table 38. U.S. Stem Cell Company Profile and Main Business

Table 39. U.S. Stem Cell Neurology Clinical Trial Models, Specifications and Application

Table 40. U.S. Stem Cell Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 41. U.S. Stem Cell Recent Developments

Table 42. Lonza Company Information, Head Office, Market Area and Industry Position

Table 43. Lonza Company Profile and Main Business

Table 44. Lonza Neurology Clinical Trial Models, Specifications and Application

Table 45. Lonza Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 46. Lonza Recent Developments

Table 47. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position

Table 48. Bristol Myers Squibb Company Profile and Main Business

Table 49. Bristol Myers Squibb Neurology Clinical Trial Models, Specifications and Application

Table 50. Bristol Myers Squibb Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 51. Bristol Myers Squibb Recent Developments

Table 52. Corning Incorporated Company Information, Head Office, Market Area and Industry Position

Table 53. Corning Incorporated Company Profile and Main Business

Table 54. Corning Incorporated Neurology Clinical Trial Models, Specifications and Application

Table 55. Corning Incorporated Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 56. Corning Incorporated Recent Developments

Table 57. Vericel Corporation Company Information, Head Office, Market Area and Industry Position

Table 58. Vericel Corporation Company Profile and Main Business

Table 59. Vericel Corporation Neurology Clinical Trial Models, Specifications and Application

Table 60. Vericel Corporation Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 61. Vericel Corporation Recent Developments

Table 62. Catalent Company Information, Head Office, Market Area and Industry Position

Table 63. Catalent Company Profile and Main Business

Table 64. Catalent Neurology Clinical Trial Models, Specifications and Application

Table 65. Catalent Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 66. Catalent Recent Developments

Table 67. Lineage Cell Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 68. Lineage Cell Therapeutics Company Profile and Main Business

Table 69. Lineage Cell Therapeutics Neurology Clinical Trial Models, Specifications and Application

Table 70. Lineage Cell Therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 71. Lineage Cell Therapeutics Recent Developments

Table 72. Castle Creek Biosciences Company Information, Head Office, Market Area and Industry Position

Table 73. Castle Creek Biosciences Company Profile and Main Business

Table 74. Castle Creek Biosciences Neurology Clinical Trial Models, Specifications and Application

Table 75. Castle Creek Biosciences Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 76. Castle Creek Biosciences Recent Developments

Table 77. Sangamo Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 78. Sangamo Therapeutics Company Profile and Main Business

Table 79. Sangamo Therapeutics Neurology Clinical Trial Models, Specifications and Application

Table 80. Sangamo Therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 81. Sangamo Therapeutics Recent Developments

Table 82. Novartis Company Information, Head Office, Market Area and Industry Position

Table 83. Novartis Company Profile and Main Business

Table 84. Novartis Neurology Clinical Trial Models, Specifications and Application

Table 85. Novartis Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 86. Novartis Recent Developments

Table 87. Holostem Terapie Avanzate S.R.L Company Information, Head Office, Market Area and Industry Position

Table 88. Holostem Terapie Avanzate S.R.L Company Profile and Main Business

Table 89. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Models, Specifications and Application

Table 90. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 91. Holostem Terapie Avanzate S.R.L Recent Developments

Table 92. Pharmicell Company Information, Head Office, Market Area and Industry Position

Table 93. Pharmicell Company Profile and Main Business

Table 94. Pharmicell Neurology Clinical Trial Models, Specifications and Application

Table 95. Pharmicell Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 96. Pharmicell Recent Developments

Table 97. Tego Science Company Information, Head Office, Market Area and Industry Position

Table 98. Tego Science Company Profile and Main Business

Table 99. Tego Science Neurology Clinical Trial Models, Specifications and Application

Table 100. Tego Science Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 101. Tego Science Recent Developments

Table 102. Autolus therapeutics Company Information, Head Office, Market Area and Industry Position

Table 103. Autolus therapeutics Company Profile and Main Business

Table 104. Autolus therapeutics Neurology Clinical Trial Models, Specifications and Application

Table 105. Autolus therapeutics Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 106. Autolus therapeutics Recent Developments

Table 107. Bayer AG Company Information, Head Office, Market Area and Industry Position

Table 108. Bayer AG Company Profile and Main Business

Table 109. Bayer AG Neurology Clinical Trial Models, Specifications and Application

Table 110. Bayer AG Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 111. Bayer AG Recent Developments

Table 112. Sartorius AG Company Information, Head Office, Market Area and Industry Position

Table 113. Sartorius AG Company Profile and Main Business

Table 114. Sartorius AG Neurology Clinical Trial Models, Specifications and Application

Table 115. Sartorius AG Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 116. Sartorius AG Recent Developments

Table 117. Daiichi Sankyo Company Information, Head Office, Market Area and Industry Position

Table 118. Daiichi Sankyo Company Profile and Main Business

Table 119. Daiichi Sankyo Neurology Clinical Trial Models, Specifications and Application

Table 120. Daiichi Sankyo Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 121. Daiichi Sankyo Recent Developments

Table 122. Takeda Pharmaceutical Company Company Information, Head Office, Market Area and Industry Position

Table 123. Takeda Pharmaceutical Company Company Profile and Main Business

Table 124. Takeda Pharmaceutical Company Neurology Clinical Trial Models, Specifications and Application

Table 125. Takeda Pharmaceutical Company Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 126. Takeda Pharmaceutical Company Recent Developments

Table 127. Sumitomo Chemical Co Company Information, Head Office, Market Area and Industry Position

Table 128. Sumitomo Chemical Co Company Profile and Main Business

Table 129. Sumitomo Chemical Co Neurology Clinical Trial Models, Specifications and Application

Table 130. Sumitomo Chemical Co Neurology Clinical Trial Revenue and Gross Margin, 2019-2024

Table 131. Sumitomo Chemical Co Recent Developments

List of Figure

Figure 1. Neurology Clinical Trial Picture

Figure 2. Global Neurology Clinical Trial Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Neurology Clinical Trial Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Neurology Clinical Trial Market Share of Global

Figure 5. Global Neurology Clinical Trial Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Neurology Clinical Trial Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Neurology Clinical Trial Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Neurology Clinical Trial Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Neurology Clinical Trial Industry Chain

Figure 10. Bone Marrow

Figure 11. Epidermis

Figure 12. Mesenchymal Stem Cells

Figure 13. Haematopoietic Stem Cells

Figure 14. Chondrocytes

Figure 15. By Type, Global Neurology Clinical Trial Revenue, 2019-2030, US$ Million

Figure 16. By Type, Global Neurology Clinical Trial Revenue Market Share, 2019-2030

Figure 17. Neurodegenerative Disorders

Figure 18. Cardiovascular Disorders

Figure 19. Orthopedics

Figure 20. Wound Healing

Figure 21. Other

Figure 22. By Application, Global Neurology Clinical Trial Revenue, 2019-2030, US$ Million

Figure 23. By Application, Global Neurology Clinical Trial Revenue Market Share, 2019-2030

Figure 24. By Region, Global Neurology Clinical Trial Revenue Market Share, 2019-2030

Figure 25. North America Neurology Clinical Trial Revenue & Forecasts, 2019-2030, US$ Million

Figure 26. By Country, North America Neurology Clinical Trial Revenue Market Share, 2019-2024

Figure 27. Europe Neurology Clinical Trial Revenue & Forecasts, 2019-2030, US$ Million

Figure 28. By Country, Europe Neurology Clinical Trial Revenue Market Share, 2019-2024

Figure 29. Asia Pacific Neurology Clinical Trial Revenue & Forecasts, 2019-2030, US$ Million

Figure 30. By Country/Region, Asia Pacific Neurology Clinical Trial Revenue Market Share, 2019-2024

Figure 31. South America Neurology Clinical Trial Revenue & Forecasts, 2019-2030, US$ Million

Figure 32. By Country, South America Neurology Clinical Trial Revenue Market Share, 2019-2024

Figure 33. Middle East & Africa Neurology Clinical Trial Revenue & Forecasts, 2019-2030, US$ Million

Figure 34. U.S. Neurology Clinical Trial Revenue, 2019-2030, (US$ Million)

Figure 35. By Company, U.S. Neurology Clinical Trial Market Share, 2019-2024

Figure 36. By Type, U.S. Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 37. By Application, U.S. Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 38. Europe Neurology Clinical Trial Revenue, 2019-2030, (US$ Million)

Figure 39. By Company, Europe Neurology Clinical Trial Market Share, 2019-2024

Figure 40. By Type, Europe Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 41. By Application, Europe Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 42. China Neurology Clinical Trial Revenue, 2019-2030, (US$ Million)

Figure 43. By Company, China Neurology Clinical Trial Market Share, 2019-2024

Figure 44. By Type, China Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 45. By Application, China Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 46. Japan Neurology Clinical Trial Revenue, 2019-2030, (US$ Million)

Figure 47. By Company, Japan Neurology Clinical Trial Market Share, 2019-2024

Figure 48. By Type, Japan Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 49. By Application, Japan Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 50. South Korea Neurology Clinical Trial Revenue, 2019-2030, (US$ Million)

Figure 51. By Company, South Korea Neurology Clinical Trial Market Share, 2019-2024

Figure 52. By Type, South Korea Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 53. By Application, South Korea Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 54. Southeast Asia Neurology Clinical Trial Revenue, 2019-2030, (US$ Million)

Figure 55. By Company, Southeast Asia Neurology Clinical Trial Market Share, 2019-2024

Figure 56. By Type, Southeast Asia Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 57. By Application, Southeast Asia Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 58. India Neurology Clinical Trial Revenue, 2019-2030, (US$ Million)

Figure 59. By Company, India Neurology Clinical Trial Market Share, 2019-2024

Figure 60. By Type, India Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 61. By Application, India Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 62. Middle East & Asia Neurology Clinical Trial Revenue, 2019-2030, (US$ Million)

Figure 63. By Company, Middle East & Asia Neurology Clinical Trial Market Share, 2019-2024

Figure 64. By Type, Middle East & Asia Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 65. By Application, Middle East & Asia Neurology Clinical Trial Revenue Market Share, 2022 VS 2029

Figure 66. Research Methodology

Figure 67. Breakdown of Primary Interviews

Figure 68. Bottom-up Approaches

Figure 69. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)